Elsevier

Academic Radiology

Volume 19, Issue 1, January 2012, Pages 17-25
Academic Radiology

Original investigation
Loss of White Matter Microstructural Integrity Is Associated with Adverse Neurological Outcome in Tuberous Sclerosis Complex

https://doi.org/10.1016/j.acra.2011.08.016Get rights and content

Rationale and Objectives

Tuberous sclerosis complex (TSC) is a genetic neurocutaneous syndrome in which cognitive and social-behavioral outcomes for patients vary widely in an unpredictable manner. The cause of adverse neurologic outcome remains unclear. The aim of this study was to investigate the hypothesis that disordered white matter and abnormal neural connectivity are associated with adverse neurologic outcomes.

Materials and Methods

Structural and diffusion magnetic resonance imaging was carried out in 40 subjects with TSC (age range, 0.5–25 years; mean age, 7.2 years; median age, 5 years), 12 of whom had autism spectrum disorders (ASD), and in 29 age-matched controls. Tractography of the corpus callosum was used to define a three-dimensional volume of interest. Regional averages of four diffusion scalar parameters of the callosal projections were calculated for each subject. These were the average fractional anisotropy (AFA) and the average mean, radial, and axial diffusivity.

Results

Subjects with TSC had significantly lower AFA and higher average mean, radial, and axial diffusivity values compared to controls. Subjects with TSC and ASD had significantly lower AFA values compared to those without ASD and compared to controls. Subjects with TSC without ASD had similar AFA values compared to controls.

Conclusion

Diffusion tensor scalar parameters provided measures of properties of the three-dimensional callosal projections. In TSC, changes in these parameters may reflect microstructural changes in myelination, axonal integrity, or extracellular environment. Alterations in white matter microstructural properties were associated with TSC, and larger changes were associated with TSC and ASD, thus establishing a relationship between altered white matter microstructural integrity and brain function.

Section snippets

Subjects

Forty patients (age range, 0.5–25 years) with established diagnoses of TSC and 29 age-matched control subjects were imaged using 3-T MRI. Control subjects underwent imaging as part of their routine care or as part of this research study. Each MRI study was reviewed by a pediatric neuroradiologist S.P.P., and all controls had normal MRI results and normal neurologic examination results. Controls did not undergo neuropsychological evaluation as part of this study. Recruitment of subjects and data

Patients

Forty subjects (24 male, 16 female; mean age, 7.2 years; age range, 0.5–25 years; median age, 5.0 years) underwent MRI. Only one patient had normal results on MRI. Twenty-four had clinically significant developmental delays or intellectual disabilities, and 12 had ASD (note that six patients aged < 1.5 years were not considered for formal diagnosis of ASD). Thirty patients had genetic confirmation of their clinical diagnoses with abnormalities in the Tsc1 (n = 8) and Tsc2 (n = 22) regions; in

Relation between White Matter Microstructure and the Development of Brain Function

Our study provides the first imaging data that identify an association between altered white matter microstructure and abnormal brain function in the TSC population. Moreover, a reduction in white matter integrity is seen in patients with worse neurodevelopmental outcomes (ie, in those who have ASD; Fig 3).

Several recent studies have reported DTI abnormalities in TSC of the normal-appearing white matter, indicating foci of microstructural abnormalities, depending on sample size and technique 8,

Conclusions

Our novel method of streamline density–weighted calculation of mean DTI scalar parameters allows for the incorporation of all white matter projections while compensating for volume averaging, resulting in average DTI measures of a white matter structure defined by tractography rather than by its voxels. Using streamline density weighting, we found a relation between alterations in white matter microstructure and neurologic outcomes in TSC.

The finding of decreased AFA and increased AAD, AMD, and

Acknowledgments

Thanks go to Sarah Spence, MD, PhD for critical reading of the manuscript. We gratefully acknowledge the contribution of MRI scans from John Gilmore and Martin Styner, supported by grant P50 MH064065 from the National Institutes of Health. We are indebted to the children and families who have participated in this study.

References (51)

  • D.H. Geschwind et al.

    Autism spectrum disorders: developmental disconnection syndromes

    Curr Opin Neurobiol

    (2007)
  • Y. Zhang et al.

    Atlas-guided tract reconstruction for automated and comprehensive examination of the white matter anatomy

    Neuroimage

    (2010)
  • J. Dauguet et al.

    Comparison of fiber tracts derived from in-vivo DTI tractography with 3D histological neural tract tracer reconstruction on a macaque brain

    Neuroimage

    (2007)
  • V. Wong

    Study of the relationship between tuberous sclerosis complex and autistic disorder

    J Child Neurol

    (2006)
  • F.E. Jansen et al.

    Cognitive impairment in tuberous sclerosis complex is a multifactorial condition

    Neurology

    (2008)
  • S. Clifford et al.

    Autism spectrum phenotype in males and females with fragile X full mutation and premutation

    J Autism Dev Disord

    (2007)
  • Y.J. Choi et al.

    Tuberous sclerosis complex proteins control axon formation

    Genes Dev

    (2008)
  • L. Meikle et al.

    A mouse model of tuberous sclerosis: neuronal loss of Tsc1 causes dysplastic and ectopic neurons, reduced myelination, seizure activity, and limited survival

    J Neurosci

    (2007)
  • D. Nie et al.

    Tsc2-Rheb signaling regulates EphA-mediated axon guidance

    Nat Neurosci

    (2010)
  • S. Arulrajah et al.

    Magnetic resonance imaging and diffusion-weighted imaging of normal-appearing white matter in children and young adults with tuberous sclerosis complex

    Neuroradiology

    (2009)
  • M.I. Makki et al.

    Characteristics of abnormal diffusivity in normal-appearing white matter investigated with diffusion tensor MR imaging in tuberous sclerosis complex

    AJNR Am J Neuroradiol

    (2007)
  • G. Simao et al.

    Diffusion tensor imaging of commissural and projection white matter in tuberous sclerosis complex and correlation with tuber load

    AJNR Am J Neuroradiol

    (2010)
  • T.A. Keller et al.

    A developmental study of the structural integrity of white matter in autism

    Neuroreport

    (2007)
  • E.S. Roach et al.

    Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

    J Child Neurol

    (1998)
  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed, text rev. Arlington,...
  • Cited by (104)

    • White matter disruptions related to inattention and autism spectrum symptoms in tuberous sclerosis complex

      2022, NeuroImage: Clinical
      Citation Excerpt :

      Diffusion imaging has been successfully applied in TSC to assess white matter microstructure, with findings converging on dysconnectivity due to structurally compromised and disorganised axons (Im et al., 2016; Taoka et al., 2020; Peters et al., 2012). In particular, TSC participants display reduced fractional anisotropy and increased mean diffusivity in numerous white matter tracts (Peters et al., 2012; Im et al., 2016; Krishnan et al., 2010), consistent with a reduced capacity for efficient information transfer between disparate regions. These metrics appear to be particularly altered in regions with cortical tubers and other lesions (Tsai et al., 2021).

    View all citing articles on Scopus

    Dr Sahin is supported in part by the John Merck Fund and a Junior Investigator Award from the Children’s Hospital Boston Translational Research Program. Dr Nelson is supported by grant R01 DC010290 from the National Institutes of Health (Bethesda, MD). This investigation was supported in part by grants R01 RR021885, R01 LM010033, R03 EB008680, and UL1 RR025758 from the National Institutes of Health.

    View full text